Cargando…

In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone

Health authorities carefully evaluate any change in the batch manufacturing process of a drug before and after regulatory approval. In the absence of an adequate in vitro–in vivo correlation (Level A IVIVC), an in vivo bioequivalence (BE) study is frequently required, increasing the cost and time of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tosca, Elena M., Rocchetti, Maurizio, Pérez, Elena, Nieto, Conchi, Bettica, Paolo, Moscoso del Prado, Jaime, Magni, Paolo, De Nicolao, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918143/ https://www.ncbi.nlm.nih.gov/pubmed/33673306 http://dx.doi.org/10.3390/pharmaceutics13020255

Ejemplares similares

Evaluating the bioequivalence of two pitavastatin calcium formulations based on IVIVC modeling and clinical study
por: Wang, Jiaying, et al.
Publicado: (2022)

A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in in vivo xenograft studies
por: Tosca, Elena Maria, et al.
Publicado: (2021)

IVIVC from Long Acting Olanzapine Microspheres
por: D'Souza, Susan, et al.
Publicado: (2014)

Evaluation of Bioequivalence of Two Long-Acting 20% Oxytetracycline Formulations in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017)

Development and validation of an in vitro–in vivo correlation (IVIVC) model for propranolol hydrochloride extended-release matrix formulations
por: Cheng, Chinhwa, et al.
Publicado: (2013)

Establishment of Level a In Vitro–In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study
por: Lee, Da Young, et al.
Publicado: (2022)

Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions
por: Margolskee, Alison, et al.
Publicado: (2015)

Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines
por: Mestorino, Nora, et al.
Publicado: (2016)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Application of Artificial Neural Networks to Predict the Intrinsic Solubility of Drug-Like Molecules
por: Tosca, Elena M., et al.
Publicado: (2021)

Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
por: Singhal, R., et al.
Publicado: (2011)

Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2016)

IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress
por: Mohylyuk, Valentyn, et al.
Publicado: (2020)

IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening
por: Puscas, Ina, et al.
Publicado: (2019)

In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing
por: Al-Tabakha, Moawia M., et al.
Publicado: (2020)

Confocal Raman Spectroscopy for Assessing Bioequivalence of Topical Formulations
por: Iliopoulos, Fotis, et al.
Publicado: (2023)

Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
por: Tosca, Elena M., et al.
Publicado: (2023)

Physiologically Relevant In Vitro-In Vivo Correlation (IVIVC) Approach for Sildenafil with Site-Dependent Dissolution
por: Kim, Tae Hwan, et al.
Publicado: (2019)

A two-stages global sensitivity analysis by using the δ sensitivity index in presence of correlated inputs: application on a tumor growth inhibition model based on the dynamic energy budget theory
por: De Carlo, Alessandro, et al.
Publicado: (2023)

Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations
por: Zeng, Yaohui, et al.
Publicado: (2017)

An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
por: Karalis, Vangelis D.
Publicado: (2023)

Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy
por: Tolbert, Dwain, et al.
Publicado: (2015)

Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations
por: Rasmussen, Scott C., et al.
Publicado: (2017)

Pharmacokinetics and bioequivalence of two cyclosporine oral solution formulations in cats
por: Yang, Yuxin, et al.
Publicado: (2022)

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022)

Levodopa‐carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation
por: Rosebraugh, Matthew, et al.
Publicado: (2019)

Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs
por: Saengklub, Nakkawee, et al.
Publicado: (2022)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
por: Huang, Chunqi, et al.
Publicado: (2023)

Introducing an In Vitro Liver Stability Assay Capable of Predicting the In Vivo Pharmacodynamic Efficacy of siRNAs for IVIVC
por: Basiri, Babak, et al.
Publicado: (2020)

In Vitro–In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action
por: Rath, Seeprarani, et al.
Publicado: (2023)

Newly formulated GROWJECT(®) is bioequivalent to the prior GROWJECT(®) formulation and causes less injection-associated pain
por: Owada, Yasuko, et al.
Publicado: (2021)

In silico prediction of bioequivalence of atorvastatin tablets based on GastroPlus™ software
por: Wang, Lu, et al.
Publicado: (2023)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010)

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
por: Zhao, Xiao-Ying, et al.
Publicado: (2013)

Pharmacokinetics and bioequivalence of two imidocarb formulations in cattle after subcutaneous injection
por: Wang, Honglei, et al.
Publicado: (2022)

Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects
por: Gupta, Vipul K., et al.
Publicado: (2022)

Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
por: Stević, Ivana, et al.
Publicado: (2023)

Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations
por: Wang, Lu, et al.
Publicado: (2023)

Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies
por: Kang, So-Jin, et al.
Publicado: (2023)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
por: Hill, Andrew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_698op7qq13snj1lvct5pkrkl97